“…Intriguingly, the differentiation of WJ-MSCs into osteoblasts involves different genetic/epigenetic regulatory mechanisms that work together to promote WJ-MSCs to differentiate into osteoblasts. For instance, RUNX2, a downstream target gene of the p38/MAPK signaling pathway [ 99 ], is also an important regulator of osteogenic differentiation. When JARID1B is enriched in the P1 promoter region of RUNX2 , the levels of activation marks, including histone H3ac and H3K4me3, are reduced, whereas increased levels of the suppressive mark histone H3K27me3 lead to the inhibition of RUNX2 transcription [ 34 ].…”